Men's Health: What experts say you should do if you’re exposed to the coronavirus
UC infectious disease expert says it's best to keep your distance
Dr. Carl Fichtenbaum of UC's Division of Infectious Diseases was interviewed by Men's Health magazine for a story on steps people should take if they think they've been exposed to the coronavirus.
Dr. Carl Fichtenbaum in a lab in the UC College of Medicine Division of Infectious Diseases. Photo/Joe Fuqua II/UC Creative + Brand
Dr. Fichtenbaum said that even if you're not sure, but suspect via the primary symptoms—fever, cough and shortness of breath—it's best to distance yourself and stay in quarantine.
"This is where we have to look towards the greater good of humanity," he says. "If most of us use this strategy—we can beat this virus." Read the full article here.
Men's Health also featured Dr. Fichtenbaum in an article on the claims that ibuprofen is unsafe for people with COVID-19.
Find the latest details related to coronavirus disease 2019 (covid-19) on the Centers for Disease Control and Prevention (CDC) website, and follow UC's latest information with regard to the virus.
Related Stories
Tips to avoid headaches this holiday season
December 15, 2025
A University of Cincinnati migraine expert offered a list of potential headache triggers around the holidays, and how you can try to avoid them, to 91.7 WVXU News. "There are a number of different factors that make this a very headache provocative time," said Vincent Martin, MD, professor of clinical medicine at the University of Cincinnati's College of Medicine and director of the Headache and Facial Pain Center at the Gardner Neuroscience Institute.
Leukemia and Drug Development Lab trains the next generation of scientific researchers
December 15, 2025
From undergraduate student workers to members of the Physician Scientist Training Program (PSTP), trainees in UC's Leukemia and Drug Development Lab shared their experiences of in-depth, hands-on training that contribute to real-world discoveries.
New combination treatment improves multiple myeloma outcomes
December 11, 2025
The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.